Similar articles

• Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.

  Spiers AS. Spiers AS. Haematologia (Budap). 1996;27(2):55-84. Haematologia (Budap). 1996. PMID: 14651224 Review.
• Pentostatin for the treatment of indolent lymphoproliferative disorders.

  Ho AD, Hensel M. Ho AD, et al. Semin Hematol. 2006 Apr;43(2 Suppl 2):S2-10. doi: 10.1053/j.seminhematol.2005.12.005. Semin Hematol. 2006. PMID: 16549110 Review.
• [Treatment of various lymphoproliferative syndromes with deoxycoformycin: results in 6 patients].

  Escoda L, López-Guillermo A, Formigón M, Estrach T, Cervantes F, Montserrat E, Rozman C. Escoda L, et al. Sangre (Barc). 1990 Dec;35(6):421-4. Sangre (Barc). 1990. PMID: 2087659 Spanish.
• Phase II trials of pentostatin (Nipent) in hairy cell leukemia.

  Kraut EH. Kraut EH. Semin Oncol. 2000 Apr;27(2 Suppl 5):27-31. Semin Oncol. 2000. PMID: 10877048
• Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.

  O'Dwyer PJ, Cheson BD, Leyland-Jones B, King SA, Hoth DF. O'Dwyer PJ, et al. Oncology (Williston Park). 1988 Jun;2(6):17-23, 26-7. Oncology (Williston Park). 1988. PMID: 3079330 Review.